Cimetidine repurposed as a potential immunomodulatory agent against colorectal carcinoma: A systematic review
CONCLUSION: Repurposing of existing drugs like cimetidine has a potential to offer a survival benefit by acting as an immunomodulatory agent in patients undergoing curative resection for CRC. However, the heterogeneity seen in current studies and the evolvement of adjunctive therapies for CRC warrant large-scale, well-designed prospective RCTs to establish the efficacy of cimetidine in CRC.PMID:38592456 | DOI:10.1177/10781552241247007
Source: Cancer Control - Category: Cancer & Oncology Authors: Wwm Gunasekara Jlaa Sachindra M T Madhushika Plgc Liyanage S Lekamwasam Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Databases & Libraries | Study